Not to be used in patients w/ type 1 diabetes or treatment
of diabetic ketoacidosis. Discontinue use if hypersensitivity reactions eg, anaphylaxis, angioedema & exfoliative skin conditions including Stevens-Johnson syndrome occur; or pancreatitis is suspected. Patients w/ renal insufficiency. Lower dosages are recommended in moderate & severe renal insufficiency, in ESRD patients requiring hemodialysis or peritoneal dialysis. Lower dose of sulfonylurea to reduce risk of sulfonylurea-induced hypoglycaemia. Pregnancy & lactation. Childn <18 yr. Elderly.